Validation of MELD3.0 in two centres from different continents. Tejedor M, Bellon JM, Fernandez de la Varga M, Peralta P, Montalva E, Selzner N, Berenguer M.Hepatol Commun. In press.

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry. (2024) Tejedor M, Neria F, De La Rosa G, Almohalla Álvarez C, Padilla M, Boscà Robledo A, Fundora Suárez Y, Sánchez-Bueno F, Gómez-Bravo MA, Berenguer M. Transpl Int. 2024 May 7;37:12732.

Tejedor M, Delgado A, Melero R, Fernández-Alonso V, Salcedo M, Rodríguez-Benítez P. (Apr 2023). “Tolvaptan in portal hypertension: real life experience”. Rev Esp Enferm Dig. 115(4):206. (IF 2.389 Q3).

Tejedor A, Rodríguez-Benitez P; Tejedor M. (2011) “Water, electrolyte and acid-base disturbances in the ICU” in: Management of acute renal failure. Editorial Ergón. Madrid. Ed. Poch E, Liaño F, Gainza FJ. Pg. 127-159, 2011. ISBN: 978-84-8473-894-7.

Cristina Ripoll, Joan Genescà, Isis K. Araujo, Isabel Graupera, Salvador Augustin, Marta Tejedor, Isabel Cirera, CarlesAracil, Margarita Sala, Manuel Hernandez-Guerra, Elba Llop, Angels Escorsell, Maria Vega Catalina, Nuria Cañete, Agustin Albillos, Càndid Villanueva, Juan G. Abraldes, Rafael Bañares, Jaime Bosch. (2013) “Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study”. Hepatol 2013; 58 (6): 2079-2088. (IF 12)

Pérez J, Grande LG, Achécar L, Moreno A, Fortún J, Arranz G, Tejedor M, Blázquez J, Sánchez J, Moreno A, Pian H, Bárcena R. (2011) “Case report of splenic artery steal syndrome: demonstration of portal hyperflow mechanism by anatomic variant of the splenic artery and correlation with Doppler rates”. Transplant Proc; 43: 2269-2271. (IF 1.04)

Marta Tejedor Bravo, Linette María Achécar Justo, Jorge Pérez Lasala, Víctor F Moreira Vicente, Ana Cano Ruiz, María de los Ángeles Martín Scapa. (2012) “Acute pancreatitis secondary to neuroendocrine pancreatic tumours: report of three cases and literature review”. Pancreas; 41 (3): 485-489. (IF 2.73)

Olveira A, Yebra J, Amaral C, Tejedor M, Eirás P, Hernández-Pérez M, Suárez-Cabredo C, Spigarelli I, Suárez-Ferrer C, Morales-Arráez D, Chico I, Díaz-Flores F, Rodríguez R, Llorente S, Molina E, Hernández-Guerra MN. (Nov 2021). “Retrieval and treatment of patients with primary biliary cholangitis who are lost in the health system”. Rev Esp Enferm Dig. 113(11):776-779. (IF 2.086; Q4).

Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R. (2013) “Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis”. Scand J Gastroenterol. 48(4): 487-495. (IF 2.02)

Tejedor M, Selzner N, Berenguer M. (Nov 2022) “Are MELD and MELDNa still reliable tools to predict mortality on the Liver Transplant waiting list?”. Transplantation. 106(11):2122-2136. (IF 4.939; Q1).